uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 02, 2021

FDA Warns Seller of Reishi Mushroom Supplements

On January 6, 2021, the FDA issued a warning letter to Entia Biosciences, Inc following a review of the company's website, which found statements made about the company's products Lion's Mane - All Natural Supplement, Antrodia Mushroom Powder, Maitake Mushroom Powder, Reishi Mushroom Powder, Cordyceps Mushroom Powder, and Cordyceps - All Natural Mushroom Dietary Supplement to be drug claims.

For example, Lion's Mane - All Natural Supplement was promoted with statements such as "It has been linked to having positive implications towards reducing cholesterol levels and inflammation."

See ConsumerLab's Cholesterol-Lowering Supplements Review (Sterols/Stanols and Policosanol) for tests of related products.

Reishi Mushroom Powder was promoted with statements such as "Prevention of heart disease," "Reduce high blood pressure," and "Lower high cholesterol."

See ConsumerLab's Reishi Mushroom Supplements Review for tests of related products.

In addition, the products were found to be misbranded because they do not contain adequate directions for safe use, as required by federal regulations.

For more information, use the link below.

Warning Letter: Entia Biosciences, Inc

See related warnings:

Seller of Omega-3 Warned for Making Claims to Treat Focus, Mood

Seller of Cholesterol, Weight Loss Products, and More Warned for Claims

FDA Warns Seller of Evening Primrose Oil and Beta Glucan

FDA Warns Seller of Curcumin and Cholesterol Supplements

FDA Warns Immusist for Drug Claims